Use for cannabinoid
US9168278B2 · kind B2 · utility
68Cited by
1References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 15, 2005 |
| Grant date | Oct 27, 2015 |
| Priority date | — |
| Expiry date | Jun 24, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of one or more cannabinoids in the manufacture of medicaments for use in the treatment of diseases and conditions benefiting from neutral antagonism of the CB, cannabinoid receptor. Preferably the cannabinoid is tetrahydrocannabivarin (THCV). Preferably the diseases and conditions to be treated are taken from the group: obesity, schizophrenia, epilepsy, cognitive disorders such as Alzheimer's, bone disorders, bulimia, obesity associated with type II diabetes (non-insulin dependant diabetes) and in the treatment of drug, alcohol and nicotine abuse or dependency.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.